RecruitingNot ApplicableNCT06178510

I-ASV in Cardiac Surgery

POStoperative INTELLiVENT-adaptive Support VEntilation in Cardiac Surgery Patients II (POSITiVE II) - a Randomized Clinical Trial


Sponsor

Medical University of Vienna

Enrollment

328 participants

Start Date

May 31, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

'POStoperative INTELLiVENT-adaptive support VEntilation in cardiac surgery patients II (POSITiVE II) is an investigator-initiated, international, multicenter, parallel, randomized clinical trial in patients after cardiac surgery.


Eligibility

Min Age: 18 YearsMax Age: 120 Years

Inclusion Criteria3

  • \. aged \> 18 years of age;
  • \. scheduled for elective cardiac surgery; and
  • \. expected to receive postoperative ventilation in the ICU for \> 2 hours.

Exclusion Criteria17

  • any emergency or semi-elective surgery (precluding informed written consent);
  • any surgery other than CABG, valve replacement or repair, or a combination (i.e., patients planned for surgery for congenital heart disease, or scheduled for heart transplantation are excluded);
  • enrolled in another interventional trail;
  • no written informed consent obtained;
  • history of recent pneumectomy or lobectomy;
  • history of COPD with oxygen at home;
  • body mass index \> 35;
  • preoperative forced expiratory volume in the first second (FeV1)/forced vital capacity (VC) \< 50% (if available);
  • preoperative arterial oxygen partial pressure (PaO2) \< 60 mm Hg (at room air);
  • preoperative arterial carbon dioxide partial pressure (PaCO2) \> 50 mm Hg;
  • preoperative left ventricular ejection fraction \< 30% (if available);
  • preoperative systolic pulmonary artery pressure \> 60 mm Hg (if available);
  • preoperative left ventricular mechanical support, e.g., Impella®; or
  • preoperative use of veno-venous or veno-arterial extracorporeal support
  • At the end of surgery, patients are additionally excluded if a patient:
  • cannot be weaned from the extracorporeal support; or
  • unexpectedly needs implementation of an assist device

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEINTELLiVENT-ASV.

INTELLiVENT-ASV® is a closed-loop ventilation mode that automatically adjusts respiratory rate and tidal volume according to the oxygen and ventilatory patient needs


Locations(1)

Medical University of Vienna

Vienna, Vienna, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06178510


Related Trials